Anebulo Pharmaceuticals Inc (ANEB)

$2.2

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $2.20
    $2.21
    $2.20
    downward going graph

    0.0%

    Downside

    Day's Volatility :0.45%

    Upside

    0.45%

    downward going graph
  • $1.62
    $4.05
    $2.20
    downward going graph

    26.36%

    Downside

    52 Weeks Volatility :60.0%

    Upside

    45.68%

    downward going graph

Returns

PeriodAnebulo Pharmaceuticals IncIndex (Russel 2000)
3 Months
-17.91%
0.0%
6 Months
-8.33%
0.0%
1 Year
-7.56%
0.0%
3 Years
-69.01%
-19.4%

Highlights

Market Capitalization
57.1M
Book Value
$0.19
Earnings Per Share (EPS)
-0.37
Wall Street Target Price
6.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-57.9%
Return On Equity TTM
-104.28%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
Diluted Eps TTM
-0.37
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.45
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
-0.12
EPS Estimate Next Quarter
-0.13

Analyst Recommendation

Buy
    88%Buy
    11%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Anebulo Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
9
9
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 172.73%

Current $2.20
Target $6.00

Technicals Summary

Sell

Neutral

Buy

Anebulo Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Anebulo Pharmaceuticals Inc
Anebulo Pharmaceuticals Inc
15.79%
-8.33%
-7.56%
-69.01%
-69.01%
Moderna, Inc.
Moderna, Inc.
-9.87%
21.5%
-2.91%
-60.58%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
1.84%
12.81%
47.11%
81.12%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-6.7%
24.69%
59.95%
200.63%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.28%
11.69%
35.86%
150.1%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Anebulo Pharmaceuticals Inc
Anebulo Pharmaceuticals Inc
NA
NA
NA
-0.45
-1.04
-0.58
NA
0.19
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Anebulo Pharmaceuticals Inc
Anebulo Pharmaceuticals Inc
Buy
$57.1M
-69.01%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Anebulo Pharmaceuticals Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 59.9% return, outperforming this stock by 67.5%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 200.6% return, outperforming this stock by 269.6%

Institutional Holdings

  • 22NW, LP

    20.69%
  • LVW Advisors, LLC

    2.48%
  • Nantahala Capital Management, LLC

    1.97%
  • Morgan Stanley - Brokerage Accounts

    1.54%
  • Ikarian Capital, LLC

    0.61%
  • Vanguard Group Inc

    0.59%

Company Information

Organization
Anebulo Pharmaceuticals Inc
Employees
2
CEO
Dr. Joseph F. Lawler M.D., Ph.D.
Industry
Miscellaneous

FAQs